Junyelt (Copper Gluconate, Manganese Gluconate, Potassium Iodide, Sodium Selenite, Zinc Gluconate)

Each element serves as a cofactor for specific enzymes. Copper and manganese support superoxide dismutase, protecting cells from oxidative damage. Iodine is essential for thyroid hormone synthesis. Selenium is a component of glutathione peroxidase, an important antioxidant enzyme. Zinc participates in numerous metabolic pathways, including DNA synthesis and immune cell activity. Together they help maintain normal cellular function.

The dose of Junyelt is determined by the prescribing clinician based on the patient’s laboratory values, clinical condition and nutritional requirements. The product is supplied as an injectable solution and the healthcare professional will calculate the appropriate volume and rate of infusion for each individual.

Safety data for Junyelt in pregnancy and lactation are limited. The decision to use the product should be made by a qualified healthcare provider after weighing potential benefits against possible risks to the mother and fetus or infant. In many cases, trace element supplementation may be considered when a deficiency is confirmed.

To place an order, submit an enquiry on the Junyelt product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.

Junyelt delivers a balanced combination of five essential trace elements in a single intravenous formulation, which can simplify administration compared with using separate single‑element products. This integrated approach may reduce the risk of incompatibilities and streamline dosing for patients receiving parenteral nutrition, while still providing the same therapeutic benefits as individual supplements.

Junyelt should be stored at 2‑8 °C in a refrigerator. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Inspect the product before use and discard any vial that appears discolored or contains particles.

Junyelt is administered intravenously. The healthcare professional will dilute the required volume in an appropriate carrier fluid and infuse it over a period determined by the patient’s condition and tolerance, typically under aseptic conditions in a clinical setting.

The most serious risks include severe hypersensitivity reactions such as anaphylaxis, acute renal impairment from mineral overload, and significant electrolyte disturbances that can lead to cardiac arrhythmias. Prompt recognition and management of these events are essential, and patients should be monitored during and after infusion.

Junyelt should be avoided in patients with known hypersensitivity to any of its components, those with uncontrolled thyroid disease where additional iodine could be harmful, and individuals with severe renal failure unless a specialist determines that the benefits outweigh the risks. Clinical judgment is required for all contraindications.